The event designating failure of a local treatment strategy should be decided at a multidisciplinary tumorboard as soon as further local treatment of newly arising lesions is no longer reasonably ...
Secondary outcomes by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR) treated with enzalutamide (enza) plus leuprolide (combo): EMBARK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results